Skip to main content

News Archive

News Archive - School of Medicine

UC San Diego Named Stem Cell “Alpha Clinic”

October 23, 2014

In a push to further speed clinical development of emerging stem cell therapies, Sanford Stem Cell Clinical Center at UC San Diego Health System was named today one of three new “alpha clinics” by the California Institute for Regenerative Medicine, the state’s stem cell agency.

Richard Kronick Elected to Institute of Medicine

October 20, 2014

Richard Kronick, PhD, a health policy expert and faculty member at University of California, San Diego School of Medicine, has been elected to the prestigious Institute of Medicine, the health arm of the National Academy of Sciences and widely regarded as one of the nation’s most respected scientific society.

Promise Put to the Test

October 20, 2014

UC San Diego Sanford Stem Cell Clinical Center is pushing therapeutic stem cell-based science out of the laboratory and closer to real-world medical applications. The unprecedented trials involve potential therapies for spinal cord injuries, Type 1 diabetes and chronic lymphocytic leukemia.

PTPRZ-MET Fusion Protein: A New Target for Personalized Brain Cancer Treatment

October 13, 2014

Researchers at the University of California, San Diego School of Medicine have identified a new fusion protein found in approximately 15 percent of secondary glioblastomas or brain tumors. The finding offers new insights into the cause of this cancer and provides a therapeutic target for personalized oncologic care.

Big Data Sharing for Better Health

October 10, 2014

Researchers at University of California, San Diego School of Medicine have been awarded a $9.2 million grant to help modernize and transform how researchers share, use, find and cite biomedical datasets.

Researchers Unfold New Details About a Powerful Protein

October 9, 2014

Using X-rays and neutron beams, a team of researchers from the University of California, San Diego School of Medicine, University of Utah and Oak Ridge National Laboratory have teased out new information about Protein Kinase A (PKA), a ubiquitous master switch that helps regulate fundamental cellular functions like energy consumption and interactions with hormones, neurotransmitters and drugs.

Two UC San Diego Scientists Honored for Schizophrenia Research

October 7, 2014

Two professors of psychiatry at University of California, San Diego School of Medicine have been honored by the New York City-based Brain & Behavior Research Foundation for their work studying the genetics, dysfunction and treatment of schizophrenia, a chronic and severe brain disorder affecting roughly 1 percent of the general population or approximately 3 million people.

New At-Risk Group Identified for Gastrointestinal Stromal Tumors

October 7, 2014

Researchers at the University of California, San Diego School of Medicine have, for the first time, clearly defined the epidemiology of gastrointestinal stromal tumors (GIST), which occur primarily in the lining of the stomach and small intestine. One key finding: Patients of Asian descent, who have not previously been identified as an at-risk population, are 1.5 times more likely than other patient groups to be diagnosed with this type of tumor.

Live and Let-7: MicroRNA Plays Surprising Role in Cell Survival

October 7, 2014

Researchers at the University of California, San Diego School of Medicine have identified a microRNA molecule as a surprisingly crucial player in managing cell survival and growth. The findings underscore the emerging recognition that non-coding RNAs help regulate basic cellular processes and may be key to developing new drugs and therapies.

Scientists Discover Pain Receptor on T-Cells

October 5, 2014

Researchers at University of California, San Diego School of Medicine have discovered that T-cells – a type of white blood cell that learns to recognize and attack microbial pathogens – are activated by a pain receptor.
Category navigation with Social links